RecruitingISRCTN47913690

Metformin plus usual care to limit weight gain when starting antipsychotics for psychosis

About this title

Metformin in psychosis for weight gain prevention

Research studyAges 16–65United KingdomSchizophrenia

The study in practice

Understand this study

Listed age limits: 16 years to 65 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Pennine Care NHS Foundation Trust
Sponsor type: Non-profit organization
Study type: Other
Intervention type: Other / unclear
Locations: United Kingdom
Age range: From 16 Years to 65 Years
Official registry ID: ISRCTN47913690
Official title: Show the full official title
A study looking at whether metformin (a diabetes drug) can prevent weight gain caused by antipsychotics in people experiencing their first episode of psychosis

Currently recruiting

United Kingdom

FAQ

Who is behind this study?

The study sponsor is Pennine Care NHS Foundation Trust.

Who can participate?

Listed age limits: 16 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.